Balveen Kaur

Balveen Kaur

Solid Tumor Biology Program, The Ohio State University Medical Center

Affiliated withThe Ohio State University Medical Center

Research Area

Biography

Balveen Kaur has not added Biography.
If you are Balveen Kaur and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
<em>In Vivo</em> Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles
Publication title

Cited by 13

2014

Other Publications

Article
Year
Genetic and biologic progression in astrocytomas and their relation to angiogenic dysregulation.

Advances in anatomic pathology| PubMed ID: 11756757

2002
2002
2002
Genetic modulation of hypoxia induced gene expression and angiogenesis: relevance to brain tumors.

Frontiers in bioscience : a journal and virtual library| PubMed ID: 12456339

2003
2003
2004
Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 15623644

2004
Genetic and hypoxic regulation of angiogenesis in gliomas.

Journal of neuro-oncology| PubMed ID: 15674480

2004
2005
2005
Gene therapeutics: the future of brain tumor therapy?

Expert review of anticancer therapy| PubMed ID: 16831077

2006
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 16908838

2006
2006
Personalizing oncolytic virotherapy?

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 17164767

2007
Oncolytic viruses driven by tumor-specific promoters.

Current cancer drug targets| PubMed ID: 17346110

2007
Oncolytic viruses: extreme treatment for an extreme disease.

Future microbiology| PubMed ID: 17661625

2006
2007
Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy.

Journal of the National Cancer Institute| PubMed ID: 18042934

2007
Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 18545226

2008
Advances in oncolytic virus therapy for glioma.

Recent patents on CNS drug discovery| PubMed ID: 19149710

2009
2009
2009
2009
Enhanced antitumor efficacy of vasculostatin (Vstat120) expressing oncolytic HSV-1.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 19844198

2010
2009
2010
Directing systemic oncolytic viral delivery to tumors via carrier cells.

Cytokine & growth factor reviews| PubMed ID: 20226717

2010
Impact of tumor microenvironment on oncolytic viral therapy.

Cytokine & growth factor reviews| PubMed ID: 20399700

2010
Chondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 21177410

2011
2011
Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress.

Current pharmaceutical biotechnology| PubMed ID: 21740359

2012
Phase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 21844505

2011
Antitumor efficacy of 34.5ENVE: a transcriptionally retargeted and "Vstat120"-expressing oncolytic virus.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 22031239

2012
2012
2012
2012
MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 22431589

2012
Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 22753591

2012
2012
2012
Bimodal anti-glioma mechanisms of cilengitide demonstrated by novel invasive glioma models.

Neuropathology : official journal of the Japanese Society of Neuropathology| PubMed ID: 22989076

2013
Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 23070115

2013
2012
VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 23481323

2013
2013
2013
2013
Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastoma.

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 23732993

2013
2013
2013
2013
DNA demethylating agents synergize with oncolytic HSV1 against malignant gliomas.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 24056786

2013
2014